2.9(top 20%)
impact factor
1.2K(top 20%)
papers
17.5K(top 10%)
citations
55(top 10%)
h-index
3.1(top 20%)
impact factor
1.3K
all documents
19.0K
doc citations
83(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Psychological and metabolic stress: A recipe for accelerated cellular aging?Hormones2009335
2Selenium intake, status, and health: a complex relationshipHormones2020234
3Bisphosphonate-associated adverse eventsHormones2009231
4Adiponectin: Regulation of its production and its role in human diseasesHormones2012216
5Diabetes and lipid metabolismHormones2018192
6Pregnancy-Induced hypertensionHormones2015189
7Impact of environmental endocrine disrupting chemicals on the development of obesityHormones2010154
8Metabolic syndrome: an update on diagnostic criteria, pathogenesis, and genetic linksHormones2018143
9The human skin as a hormone target and an endocrine glandHormones2004142
10The role of the Wnt signaling pathway in osteoblast commitment and differentiationHormones2007136
11Sarcopenic obesityHormones2018129
12Increasing world incidence of thyroid cancer: Increased detection or higher radiation exposure?Hormones2010126
13Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemicHormones2021124
14Environmental chemicals targeting thyroidHormones2010116
15Androgen insensitivity syndrome: clinical features and molecular defectsHormones2008114
16Sex differences in stress responses: a critical role for corticotropin-releasing factorHormones2018111
17Exercise and the stress systemHormones2005111
18Ectopic thyroid: etiology, pathology and managementHormones2011110
19Advanced glycation end products and diabetic complications: A General overviewHormones2005110
20Neuroendocrine targets of endocrine disruptorsHormones2010108
21Thyroid function during critical illnessHormones2011104
22Polycystic Ovary Syndrome: The influence of environmental and genetic factorsHormones2006104
23Complications and risk factors related to the extent of surgery in thyroidectomy. Results from 2,043 proceduresHormones2010100
24The use of bisphosphonates in women prior to or during pregnancy and lactationHormones201196
25Hashimoto’s Thyroiditis: History and Future OutlookHormones201395
26Effect of zinc supplementation on insulin resistance and components of the metabolic syndrome in prepubertal obese childrenHormones200988
27Genotype-phenotype relationship in multiple endocrine neoplasia type 2. Implications for clinical managementHormones200986
28The impact of adipose tissue-derived factors on the hypothalamic-pituitary-gonadal (HPG) axisHormones201586
29Predictors of amputation in diabetics with foot ulcer: Single center experience in a large Turkish cohortHormones200985
30Obesity and bone metabolismHormones201885
31Metformin and gut microbiota: their interactions and their impact on diabetesHormones201983
32Improvement of insulin sensitivity in patients with type 2 diabetes mellitus after oral administration of alpha-lipoic acidHormones200683
33Bisphenol-A: a new diabetogenic factor?Hormones201080
34Impact of dietary modification of advanced glycation end products (AGEs) on the hormonal and metabolic profile of women with polycystic ovary syndrome (PCOS)Hormones201479
35Autoimmunity in differentiated thyroid cancer: Significance and related clinical problemsHormones201074
36Thyroid nodules - Stepwise diagnosis and managementHormones200774
37Aging and glycoxidant stressHormones200872
38Thyroid hormones and agingHormones200872
39Serum and glucocorticoid inducible kinase, metabolic syndrome, inflammation, and tumor growthHormones201372
40Chronic stress and body composition disorders: implications for health and diseaseHormones201871
41Effect of weight loss with or without orlistat treatment on adipocytokines, inflammation, and oxidative markers in obese womenHormones200671
42The GH-IGF1 axis and longevity. The paradigm of IGF1 deficiencyHormones200869
43The spectrum of phytoestrogens in nature: our knowledge is expandingHormones200769
44Adrenal incidentaloma: a diagnostic challengeHormones200968
45A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndromeHormones201567
46Coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma. A retrospective studyHormones201066
47SOCS3 as a future target to treat metabolic disordersHormones201966
48Early life stress and trauma: developmental neuroendocrine aspects of prolonged stress system dysregulationHormones201865
49Effects of ghrelin in energy balance and body weight homeostasisHormones201664
50Combined therapy with L-Thyroxine and L-Triiodothyronine compared to L-Thyroxine alone in the treatment of primary hypothyroidismHormones201062